BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18634501)

  • 1. One-dose intradermal rabies booster enhances rabies antibody production and avidity maturation.
    Kewcharoenwong C; Freeouf S; Nithichanon A; Petsophonsakul W; Pornprasert S; Khamduang W; Suzuki T; Onodera T; Takahashi Y; Lertmemongkolchai G
    Med Microbiol Immunol; 2024 May; 213(1):7. PubMed ID: 38761268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India.
    Sudarshan MK; Narayana DH; Madhusudana SN; Holla R; Ashwin BY; Gangaboraiah B; Ravish HS
    Hum Vaccin Immunother; 2012 Aug; 8(8):1077-81. PubMed ID: 22699446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of antibody titres between intradermal and intramuscular rabies vaccination using inactivated vaccine in cattle in Bhutan.
    Wangmo K; Laven R; Cliquet F; Wasniewski M; Yang A
    PLoS One; 2019; 14(6):e0209946. PubMed ID: 31181078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplification of Rabies Postexposure Prophylaxis: A New 2-Visit Intradermal Vaccine Regimen.
    Warrell MJ
    Am J Trop Med Hyg; 2019 Dec; 101(6):1199-1201. PubMed ID: 31392953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boostability after single-visit pre-exposure prophylaxis with rabies vaccine: a randomised controlled non-inferiority trial.
    Overduin LA; Koopman JPR; Prins C; Verbeek-Menken PH; De Pijper CA; Eblé PL; Heerink F; van Genderen PJJ; Grobusch MP; Visser LG
    Lancet Infect Dis; 2024 Feb; 24(2):206-216. PubMed ID: 37802090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response after rabies vaccine in a kidney transplant recipient.
    Rodríguez-Romo R; Morales-Buenrostro LE; Lecuona L; Escalante-Santillán N; Velasco-Villa A; Kuzmin I; Rupprecht CE; De-Leo C; Ramírez J; Alberú J
    Transpl Infect Dis; 2011 Oct; 13(5):492-5. PubMed ID: 21883758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response after rabies pre-exposure prophylaxis and a booster dose in Australian bat carers.
    Guo Y; Mills DJ; Lau CL; Mills C; Furuya-Kanamori L
    Zoonoses Public Health; 2023 Sep; 70(6):465-472. PubMed ID: 37170441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single visit rabies pre-exposure prophylaxis: A literature review.
    Damanet B; Costescu Strachinaru DI; Levêque A
    Travel Med Infect Dis; 2023; 54():102612. PubMed ID: 37394127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Survival from Clinical Rabies in a Young Child from Maharashtra, India, 2022.
    Ullas PT; Balachandran C; Pathak N; Manikrao YP; Rathod S; Pavitrakar DV; Bondre VP; Abraham P
    Am J Trop Med Hyg; 2023 Nov; 109(5):1157-1160. PubMed ID: 37783454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and feasibility of intradermal vaccination against rabies in Quebec.
    Bui Y; Sow M; Cambron-Goulet E; Levac E; Milord F
    Can Commun Dis Rep; 2015 Mar; 41(3):55-62. PubMed ID: 29769933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-exposure rabies prophylaxis: a systematic review.
    Kessels JA; Recuenco S; Navarro-Vela AM; Deray R; Vigilato M; Ertl H; Durrheim D; Rees H; Nel LH; Abela-Ridder B; Briggs D
    Bull World Health Organ; 2017 Mar; 95(3):210-219C. PubMed ID: 28250534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity.
    Suwansrinon K; Wilde H; Benjavongkulchai M; Banjongkasaena U; Lertjarutorn S; Boonchang S; Suttisri R; Khowplod P; Daviratanasilpa S; Sitprija V
    Vaccine; 2006 May; 24(18):3878-80. PubMed ID: 16530893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure.
    Warrell MJ
    Travel Med Infect Dis; 2012 Jan; 10(1):1-15. PubMed ID: 22342356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing rabies with the Verorab vaccine: 1985-2005 Twenty years of clinical experience.
    Toovey S
    Travel Med Infect Dis; 2007 Nov; 5(6):327-48. PubMed ID: 17983973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One or three intradermal injections within one week for rabies pre-exposure immunization.
    Khawplod P; Wilde H; Sriaroon C; Chomchey P; Kamolthum T; Sitprija V
    Dev Biol (Basel); 2008; 131():393-401. PubMed ID: 18634501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity study of abbreviated rabies preexposure vaccination schedules.
    Khawplod P; Wilde H; Benjavongkulchai M; Sriaroon C; Chomchey P
    J Travel Med; 2007; 14(3):173-6. PubMed ID: 17437473
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.